{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T04:33:41Z","timestamp":1745469221032,"version":"3.40.4"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1097\/aci.0b013e32835b35d5","type":"journal-article","created":{"date-parts":[[2012,12,14]],"date-time":"2012-12-14T11:23:46Z","timestamp":1355484226000},"page":"13-18","source":"Crossref","is-referenced-by-count":10,"title":["Role of interleukin-32 in chronic rhinosinusitis"],"prefix":"10.1097","volume":"13","author":[{"given":"Anjeni","family":"Keswani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Schleimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210128","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4065\/mcp.2010.0392","article-title":"Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines. Mayo Clinic proceedings.","volume":"86","author":"Meltzer","year":"2011","journal-title":"Mayo Clinic"},{"key":"R2-4-20210128","first-page":"213","article-title":"Chronic rhinosinusitis with and without nasal polyps: what is the difference Curr Allergy Asthma R","volume":"9","author":"Huvenne","year":"2009","journal-title":"ep"},{"key":"R3-4-20210128","first-page":"131","article-title":"Interleukin-32: a cytokine and inducer of TNFalpha.","volume":"22","author":"Kim","year":"2005","journal-title":"Immunity"},{"issue":"Suppl 3","key":"R4-4-20210128","doi-asserted-by":"crossref","first-page":"iii61","DOI":"10.1136\/ard.2006.058511","article-title":"IL-32 a novel cytokine with a possible role in disease.","volume":"65","author":"Dinarello","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R5-4-20210128","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4049\/jimmunol.148.2.597","article-title":"Identification of a novel gene expressed in activated natural killer cells and T cells.","volume":"148","author":"Dahl","year":"1992","journal-title":"J Immunol"},{"key":"R6-4-20210128","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1074\/jbc.M111.288290","article-title":"Interleukin 32 (IL-32) contains a typical alpha-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1.","volume":"287","author":"Heinhuis","year":"2012","journal-title":"J Biol Chem"},{"key":"R7-4-20210128","doi-asserted-by":"crossref","first-page":"16309","DOI":"10.1073\/pnas.0508237102","article-title":"IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism.","volume":"102","author":"Netea","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-4-20210128","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1073\/pnas.0813334106","article-title":"IL-32-dependent effects of IL-1beta on endothelial cell functions.","volume":"106","author":"Nold-Petry","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9-4-20210128","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cyto.2009.10.003","article-title":"Suppressing IL-32 in monocytes impairs the induction of the proinflammatory cytokines TNFalpha and IL-1beta.","volume":"49","author":"Hong","year":"2010","journal-title":"Cytokine"},{"key":"R10-4-20210128","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jaci.2010.01.016","article-title":"IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis.","volume":"125","author":"Meyer","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R11-4-20210128","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/intimm\/dxh339","article-title":"Involvement of IL-32 in activation-induced cell death in T cells.","volume":"18","author":"Goda","year":"2006","journal-title":"Int Immunol"},{"key":"R12-4-20210128","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1371\/journal.pmed.0030277","article-title":"Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1IL-18interferon-gamma-dependent mechanism.","volume":"3","author":"Netea","year":"2006","journal-title":"PLoS Med"},{"key":"R13-4-20210128","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/intimm\/dxr075","article-title":"IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease.","volume":"23","author":"Bai","year":"2011","journal-title":"Int Immunol"},{"key":"R14-4-20210128","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.4049\/jimmunol.1100277","article-title":"The immunosuppressive role of IL-32 in lymphatic tissue during HIV-1 infection.","volume":"186","author":"Smith","year":"2011","journal-title":"J Immunol"},{"key":"R15-4-20210128","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.imlet.2008.01.007","article-title":"Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication.","volume":"117","author":"Rasool","year":"2008","journal-title":"Immunol Lett"},{"key":"R16-4-20210128","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4049\/jimmunol.181.1.557","article-title":"Endogenous IL-32 controls cytokine and HIV-1 production.","volume":"181","author":"Nold","year":"2008","journal-title":"J Immunol"},{"key":"R17-4-20210128","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jinf.2012.05.009","article-title":"Increased interleukin-32 expression in chronic hepatitis B virus-infected liver.","volume":"65","author":"Xu","year":"2012","journal-title":"J Infect"},{"key":"R18-4-20210128","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/hep.24285","article-title":"Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.","volume":"53","author":"Moschen","year":"2011","journal-title":"Hepatology"},{"key":"R19-4-20210128","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cyto.2011.12.024","article-title":"Characterizing antiviral mechanism of interleukin-32 and a circulating soluble isoform in viral infection.","volume":"58","author":"Bae","year":"2012","journal-title":"Cytokine"},{"key":"R20-4-20210128","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.4049\/jimmunol.0902667","article-title":"IL-32: a host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection.","volume":"185","author":"Li","year":"2010","journal-title":"J Immunol"},{"key":"R21-4-20210128","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.4049\/jimmunol.1000081","article-title":"Protection from RNA and DNA viruses by IL-32.","volume":"186","author":"Zepp","year":"2011","journal-title":"J Immunol"},{"key":"R22-4-20210128","first-page":"289","article-title":"Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokinechemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes.","volume":"16","author":"Cagnard","year":"2005","journal-title":"Eur Cytokine Netw"},{"key":"R23-4-20210128","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/ard.2010.139196","article-title":"Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade.","volume":"70","author":"Heinhuis","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R24-4-20210128","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1073\/pnas.0511233103","article-title":"IL-32, a proinflammatory cytokine in rheumatoid arthritis.","volume":"103","author":"Joosten","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R25-4-20210128","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2249.2007.03439.x","article-title":"Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease.","volume":"149","author":"Shioya","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"R26-4-20210128","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jaci.2011.12.1002","article-title":"Inhibition of angiogenesis by IL-32: possible role in asthma.","volume":"129","author":"Meyer","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"R27-4-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1398-9995.2011.02706.x","article-title":"Differential expression of interleukin-32 in chronic rhinosinusitis with and without nasal polyps.","volume":"67","author":"Keswani","year":"2012","journal-title":"Allergy"},{"key":"R28-4-20210128","first-page":"141","article-title":"IL-32: a newly-discovered proinflammatory cytokine.","volume":"23","author":"Felaco","year":"2009","journal-title":"J Biol Regul Homeost Agents"},{"key":"R29-4-20210128","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1164\/rccm.200804-646OC","article-title":"IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.","volume":"178","author":"Calabrese","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R30-4-20210128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1465-9921-13-19","article-title":"Oxidative stress induced interleukin-32 mRNA expression in human bronchial epithelial cells.","volume":"13","author":"Kudo","year":"2012","journal-title":"Respir Res"},{"key":"R31-4-20210128","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/path.2899","article-title":"IL-32 up-regulation is associated with inflammatory cytokine production in allergic rhinitis.","volume":"224","author":"Jeong","year":"2011","journal-title":"J Pathol"},{"key":"R32-4-20210128","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1073\/pnas.0712391105","article-title":"Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function.","volume":"105","author":"Marcondes","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R33-4-20210128","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1164\/rccm.200903-0400OC","article-title":"Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype.","volume":"180","author":"Sorrentino","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"R35-4-20210128","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2567.2011.03513.x","article-title":"Interleukin-32 enhances cytotoxic effect of natural killer cells to cancer cells via activation of death receptor 3.","volume":"135","author":"Park","year":"2012","journal-title":"Immunology"},{"key":"R36-4-20210128","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1038\/onc.2011.52","article-title":"IL-32gamma inhibits cancer cell growth through inactivation of NF-kappaB and STAT3 signals.","volume":"30","author":"Oh","year":"2011","journal-title":"Oncogene"},{"key":"R37-4-20210128","doi-asserted-by":"crossref","first-page":"12049","DOI":"10.1074\/jbc.M110.159756","article-title":"Overexpression of IL-32alpha increases natural killer cell-mediated killing through up-regulation of Fas and UL16-binding protein 2 (ULBP2) expression in human chronic myeloid leukemia cells.","volume":"286","author":"Cheon","year":"2011","journal-title":"J Biol Chem"},{"key":"R38-4-20210128","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s00415-011-6036-7","article-title":"Elevated serum level of interleukin-32alpha in the patients with myasthenia gravis.","volume":"258","author":"Na","year":"2011","journal-title":"J Neurol"},{"key":"R39-4-20210128","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/art.30374","article-title":"Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritis.","volume":"63","author":"Ciccia","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R41-4-20210128","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1398-9995.2012.02820.x","article-title":"Regulation and expression of IL-32 in chronic rhinosinusitis.","volume":"67","author":"Soyka","year":"2012","journal-title":"Allergy"},{"key":"R42-4-20210128","first-page":"81","article-title":"Cytokineanticytokine therapy - novel treatments for asthma Br J P","volume":"163","author":"Hansbro","year":"2011","journal-title":"harmacol"},{"key":"R43-4-20210128","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000323299","article-title":"The role of cytokineschemokines in the pathogenesis of atopic dermatitis.","volume":"41","author":"Yamanaka","year":"2011","journal-title":"Curr Probl Dermatol"},{"key":"R44-4-20210128","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1136\/ard.2009.127399","article-title":"IL-32gamma and Streptococcus pyogenes cell wall fragments synergise for IL-1-dependent destructive arthritis via upregulation of TLR-2 and NOD2.","volume":"69","author":"Heinhuis","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R45-4-20210128","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jaci.2009.10.072","article-title":"Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps.","volume":"125","author":"Peters","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R46-4-20210128","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1365-2222.2005.02316.x","article-title":"Nasal biomarker profiles in acute and chronic rhinosinusitis.","volume":"35","author":"Riechelmann","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"R47-4-20210128","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jaci.2004.07.013","article-title":"Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis.","volume":"114","author":"Van Zele","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"R48-4-20210128","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2500\/ajra.2012.26.3718","article-title":"Biofilm formation and Toll-like receptor 2, Toll-like receptor 4, and NF-kappaB expression in sinus tissues of patients with chronic rhinosinusitis.","volume":"26","author":"Sun","year":"2012","journal-title":"Am J Rhinol Allergy"},{"key":"R49-4-20210128","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fcimb.2012.00043","article-title":"Intracellular staphylococcus aureus: live-in and let die.","volume":"2","author":"Fraunholz","year":"2012","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Current Opinion in Allergy & Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACI.0b013e32835b35d5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T18:15:13Z","timestamp":1745432113000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130832-201302000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0b013e32835b35d5","relation":{},"ISSN":["1528-4050"],"issn-type":[{"type":"print","value":"1528-4050"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}